通讯作者: 刘雪杨, 1481160154@qq.com

DOI：10.12201/bmr.202506.00015

Progress in the treatment of blood hypercoagulability in patients with non-small cell lung cancer

• 摘要：基于临床数据发现非小细胞肺癌患者普遍存在血液高凝状态,而血液高凝状态会促进疾病进展,并会引起包括静脉血栓栓塞等并发症,是导致患者死亡的重要因素。西医认为造成血液高凝状态的成因复杂多样,有血管内皮损伤、组织因子异常、抗凝及纤溶系统抑制等。中医认为有因虚致瘀、因毒致瘀、七情致瘀、血出致瘀。文章对非小细胞肺癌患者血液高凝状态的发生机制、中医病机及中西医治疗进展做简要综述,为伴有血液高凝状态的非小细胞肺癌患者治疗提供一定参考。

  关键词： 非小细胞肺癌; 血液高凝状态; 治疗; 血瘀

   

  Abstract: Based on clinical data, it is found that non-small cell lung cancer patients generally have hypercoagulable state of blood, and hypercoagulable state of blood promotes disease progression and causes complications including venous thromboembolism, which is an important factor leading to the death of patients. According to Western medicine, the causes of hypercoagulability are complex and varied, including vascular endothelial damage, tissue factor abnormality, inhibition of anticoagulant and fibrinolytic systems, and so on. Chinese medicine believes that there are stasis due to deficiency, stasis due to toxicity, stasis due to seven emotions, and stasis due to blood outflow. The article provides a brief review of the occurrence mechanism of hypercoagulability in non-small cell lung cancer patients, the pathogenesis of Chinese medicine, and the progress of Chinese and Western medicine treatment, so as to provide a certain reference for the treatment of non-small cell lung cancer patients with hypercoagulability.

  Key words: Non-small cell lung cancer; hypercoagulable state of blood; treatment; extravasated blood

  提交时间：2025-06-07

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 李娜, 罗炳清. 微波消融联合化疗+PD-1抑制剂治疗非小细胞肺癌的临床观察. 2025. doi: 10.12201/bmr.202504.00054

  郑歆. PD-1免疫诱导治疗在不可切除Ⅲ期NSCLC中的研究进展. 2025. doi: 10.12201/bmr.202501.00025

  陈传爱. 红细胞存储损伤的研究进展. 2025. doi: 10.12201/bmr.202502.00021

  孙姚承, 汤建军, 张伟元, 刘传磊. 结直肠癌患者检测治疗前血D-二聚体和CEA的临床意义. 2024. doi: 10.12201/bmr.202409.00023

  季兴祖, 郑勇飞, 周敏华, 叶益平. 基于数据挖掘研究叶益平治疗肺癌用药规律. 2024. doi: 10.12201/bmr.202407.00030

  孟丽红, 关炜, 薛晓明. 中药靶向肺泡上皮细胞衰老治疗肺纤维化的研究进展. 2025. doi: 10.12201/bmr.202506.00012

  李昱, 杨涛, 胡孔法. 基于层次社团划分算法的名老中医治疗肺癌的用药规律研究. 2021. doi: 10.12201/bmr.202110.00020

  陈芸琪, 栾志勇. 干细胞治疗先天性巨结肠的研究进展. 2024. doi: 10.12201/bmr.202410.00021

  姚根武, 王彦伟, 郭琎祎, 李露露, 党文博, 宋爱琳. 单细胞测序技术在乳腺癌中的研究进展. 2024. doi: 10.12201/bmr.202407.00053

  林小雷, 马光泛, 陈小珍, 周森. 艾司氯胺酮对乳腺癌患者术后精神状态的影响. 2024. doi: 10.12201/bmr.202412.00054

• 序号	提交日期	编号	操作
  1	2025-05-03	bmr.202506.00015V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论